Research project led by Bailey Hanna, MS, RDN - no affiliate links, ads or sponsored products.
After analyzing over 40 probiotics across 69 trials, we’ve identified the most promising probiotics for managing constipation in IBS. Our dataset (below) is ordered based on an automated scoring system, which we further refined using additional criteria (below) to select our top choices. Here are the results of our findings.
Our Top Choice(s)
Bacillus coagulans Unique IS-2 ranked #1 based on its strong performance in both adults and children. It demonstrated significant improvements in constipation-related symptoms such as straining and incomplete evacuation.
Although these studies included various IBS subtypes, the significant improvements in constipation-related symptoms earned Unique IS-2 the top spot in our rankings.
Honorable Mention
Probio-tec also showed promising results, with a significant reduction in feelings of incomplete defecation compared to placebo (Cohen’s d = 0.77). However, it was not included in the top rankings due to its lack of commercial availability. (3)
Our Criteria
The probiotics in our full database (below) are automatically ranked based on their 1) effect size for constipation relief, followed by 2) effect size for overall IBS symptoms (‘Global IBS Symptoms’), and finally by 3) the quality of evidence from the studies.
For this summary, we selected our top choices based on these rankings, along with the following additional criteria:
No Direct Comparisons
It’s important to note that we do not have direct comparisons between probiotics in our database across identical groups or study methods. Therefore, we cannot definitively rank one probiotic as superior to another. Bacillus coagulans Unique IS-2 has shown promise in managing constipation-related symptoms in IBS, but always consult your healthcare provider before starting any new probiotic or supplement.
*Effect sizes are reported as the weighted mean effect size across studies.
*Population values represent the per protocol population size from studies specifically assessing a constipation-related parameter.
References:
Honorable mention: Probio-tec (not commercially available)
Add condition
Statistically significant improvement and a Cohen’s d or h of ≥ 1.0
Statistically significant improvement and a Cohen’s d or h of 0.5 – 1.0
Statistically significant improvement and a Cohen’s d or h of <0.5
No statistically significant effect
Not studied
Adverse effects measured
When selecting our top probiotic picks, we ensure they are commercially available and backed by high-quality evidence, with an average score above 75% for the relevant symptom parameters. The probiotics must also demonstrate a moderate to high effect size (>0.5) for these symptoms. If there are more than five candidates, we limit our top picks to the best five based on the effect size for relevant symptoms and Global IBS symptoms, as well as evidence quality. This ensures our recommendations are practical and reliable.